Many clinicians have to make critical blood therapy decisions based on the limited snapshots provided by traditional tests – tests that simply weren’t designed to provide them with the timely, relevant and comprehensive results they need ^(1-4). Effective hemostasis management requires that physicians have the most complete information to make decisions on how to best maintain and/or restore a patient’s coagulation equilibrium.

Literature and ongoing trials have shown by adding the TEG^® Hemostasis Analyzer System to your clinical practice and blood management program, you can help predict and manage coagulopathy ^(3-8), help assess the risk for re-operation ^(9-10), and realize cost savings through the reduction of unnecessary blood component transfusions ^(10-11).